EXINI Diagnostics AB-医療機器分野:企業M&A・提携分析

◆英語タイトル:EXINI Diagnostics AB - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012959
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EXINI Diagnostics AB (EXINI), a subsidiary of Progenics Pharmaceuticals Inc, is a healthcare IT company that offers development of software solutions for the medical diagnostic market. The company’s software solutions include EXINIbone, EXINIheart, EXINIbrain and EXINIdat. Its EXINIbone is used in analysis of bone scintigraphy; and EXINIheart provides analysis of myocardial perfusion scintigraphy. EXINI’s EXINIbrain is used for diagnosing dementia by processing cerebral blood flow scans; and EXINIdat is used for diagnosing Parkinsonian syndromes using quantification of striatal uptake. The company provides image analysis, display of images, pre-selection of hotspot, bone scan index and qualification, Bone scan index report, handling of large databases, and artificial neural networks for increasing accuracy and improving clinical time-flow. It offers products in the fields of oncology, cardiology, and neurology. The company serves in quality, patenting, marketing and publicizing. EXINI is headquartered in Lund, Sweden.

EXINI Diagnostics AB – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EXINI Diagnostics AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
EXINI Diagnostics AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
EXINI Diagnostics AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
EXINI Diagnostics AB, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
EXINI Diagnostics AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
EXINI Diagnostics AB, Medical Equipment, Deal Details 10
Partnerships 10
EXINI Diagnostics Enters into Agreement with FUJIFILM RI Pharma 10
EXINI Diagnostics Enters Into Co-Development Agreement With FUJIFILM RI Pharma 11
EXINI Diagnostics Enters Into Co-Marketing Agreement With FUJIFILM RI Pharma For EXINI Heart 12
EXINI Diagnostics Enters Into Co-Marketing Agreement With FUJIFILM RI Pharma For EXINI Bone 13
Equity Offering 14
Exini Diagnostics Raises USD3 Million in Rights Offering of Shares 14
Acquisition 15
Progenics Pharma to Acquire EXINI Diagnostics for USD7 Million in Tender Offer 15
EXINI Diagnostics AB – Key Competitors 17
EXINI Diagnostics AB – Key Employees 18
EXINI Diagnostics AB – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
EXINI Diagnostics AB, Medical Equipment, Key Facts 2
EXINI Diagnostics AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
EXINI Diagnostics AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
EXINI Diagnostics AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
EXINI Diagnostics AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
EXINI Diagnostics AB, Deals By Market, 2011 to YTD 2017 8
EXINI Diagnostics AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
EXINI Diagnostics Enters into Agreement with FUJIFILM RI Pharma 10
EXINI Diagnostics Enters Into Co-Development Agreement With FUJIFILM RI Pharma 11
EXINI Diagnostics Enters Into Co-Marketing Agreement With FUJIFILM RI Pharma For EXINI Heart 12
EXINI Diagnostics Enters Into Co-Marketing Agreement With FUJIFILM RI Pharma For EXINI Bone 13
Exini Diagnostics Raises USD3 Million in Rights Offering of Shares 14
Progenics Pharma to Acquire EXINI Diagnostics for USD7 Million in Tender Offer 15
EXINI Diagnostics AB, Key Competitors 17
EXINI Diagnostics AB, Key Employees 18

★海外企業調査レポート[EXINI Diagnostics AB-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SecureWorks Corp (SCWX):企業の財務・戦略的SWOT分析
    SecureWorks Corp (SCWX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Alsalam Aerospace Industries:企業の戦略・SWOT・財務情報
    Alsalam Aerospace Industries - Strategy, SWOT and Corporate Finance Report Summary Alsalam Aerospace Industries - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Electronic Control Security Inc.:企業の戦略・SWOT・財務情報
    Electronic Control Security Inc. - Strategy, SWOT and Corporate Finance Report Summary Electronic Control Security Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Cytox Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cytox Ltd (Cytox) is a prognostic and diagnostic service provider that develops neurodegenerative disorders services. The company offers development of tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias and its blood tests are used to predict …
  • Bacardi Ltd:企業の戦略的SWOT分析
    Bacardi Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • 2020 GeneSystems Inc-医療機器分野:企業M&A・提携分析
    Summary 20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company that develops and commercializes diagnostic tests and proteomics products for early disease detection, therapy selection and biodefense applications. The company provides tests in the areas such as personalized medicine, earl …
  • MEC Holding GmbH:企業の戦略的SWOT分析
    MEC Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Mega Lifesciences Public Co Ltd (MEGA):企業の財務・戦略的SWOT分析
    Summary Mega Lifesciences Public Co Ltd (Mega) is a manufacturer, marketer and distributor of pharmaceutical and nutraceutical products. The company provides product categories such as complimentary medicines, OTC medicines, prescription medicines, and others. It offers complimentary medicines such …
  • Louisiana-Pacific Corporation:戦略・SWOT・企業財務分析
    Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report Summary Louisiana-Pacific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • American Outdoor Brands Corp:企業の戦略・SWOT・財務分析
    American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report Summary American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • IBEX Technologies Inc (IBT):企業の財務・戦略的SWOT分析
    Summary IBEX Technologies Inc (IBEX) is a manufacturer and marketer of high-purity proprietary enzymes and recombinant from flavobacterium heparinum. The company provides enzymes such as heparinase I, heparinase II, heparinase III, chondroitinase AC and chondroitinase B. Its assays allow for the stu …
  • Oric Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oric Pharmaceuticals Inc (Oric Pharmaceuticals) is an independent oncology company that focuses to discover and develop drugs for overcoming resistance in cancer. Its lead drug candidate ORIC-101, which is in phase 1 clinical trial, is a small molecule inhibitor of the glucocorticoid recepto …
  • Daiichi Sankyo Co Ltd (4568):医療機器:M&Aディール及び事業提携情報
    Summary Daiichi Sankyo Company Ltd (Daiichi Sankyo) is a holding company that carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs, vaccines, and others. Its portfolio encompa …
  • Swissgrid AG:企業の戦略的SWOT分析
    Swissgrid AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Larsen & Toubro Limited:企業の戦略・SWOT・財務情報
    Larsen & Toubro Limited - Strategy, SWOT and Corporate Finance Report Summary Larsen & Toubro Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Camel-IDS NV-製薬・医療分野:企業M&A・提携分析
    Summary Camel-IDS NV (Camel-IDS) is a biotechnology company which develops targeted radionuclide therapeutic solutions for the treatment of cancer. The company focuses on developing its lead compound radiopharmaceutical drug for treatment of Her2 positive cancer. Its technology platform is based on …
  • Top Image Systems Ltd. (TISA):企業の財務・戦略的SWOT分析
    Top Image Systems Ltd. (TISA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Revera Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Revera Inc (Revera), formerly Retirement Residences Real Estate Investment Trust, is a healthcare service provider that offers assisted living, independent living, seniors’ apartments,memory care and long term care services. The center provides person-centered care, quality care, clinical pr …
  • ITT Inc.:企業のM&A・事業提携・投資動向
    ITT Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ITT Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • SpectraCure AB (SPEC)-製薬・医療分野:企業M&A・提携分析
    Summary SpectraCure AB (SpectraCure) is a healthcare technology company that develops different methods for treatment planning and laser light dose management for cancer treatment. The company develops and therapy system (PDT) commercializes photodynamic with IDOSE for tumors. Its IDOSE platform all …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆